Quarterly out with more details on the AGC deal, upfront cash payment due next week, more broker reports coming out next week and a good news flow for the rest of the year!
They were booked to do the biotech conference in San Fran just gone but had to cancel because the deal wasn't signed off at the cut-off time and then came through after Christmas so was too late and couldn't do much about it.
Instead John will present at a bio conference in Miami USA in the coming weeks and meet with potential partners in the US and present on the deal etc.
Seems like it will all get going from now. Haven't promoted it as yet as it happened at the worst time of year. The reason it took so long was RGS wanted the very best deal and held off and got there in the end. It's a great deal when you look at it and compare to others. Well worth the wait for long term holders imo.
RGS Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
